Climb BioCLYM
13F holders, Q1 2024 (March 31)21holders
3famous investors
$2.74avg. 13F price*
At the end of Q1 2024, 21 institutions reported holding Climb Bio Inc. (CLYM) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($36.0M), BML Capital Management, LLC ($6.0M) and Driehaus Capital Management LLC ($2.2M). 3 famous investors held it, including Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Climb Bio Inc.
- Filed as
- ELIEM THERAPEUTICS INC (Q1 2024)
- CUSIP
- 28658R106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $16K |
| Exits | 3 | $37K |
Ownership 21 holders
| Ra Capital Management, L.P. | 0.46% | No change | 13,150,849 | $36.0M |
| BML Capital Management, LLC | 4.02% | Add +0.6% | 2,193,742 | $6.0M |
| Driehaus Capital Management LLC | 0.02% | No change | 811,680 | $2.2M |
| Vanguard Group Inc. | 0.00% | No change | 310,486 | $851K |
| Atom Investors LP | 0.03% | No change | 78,276 | $214K |
| Geode Capital Management, LLC | 0.00% | No change | 66,626 | $183K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 55,223 | $151K |
| Northern Trust Corp. | 0.00% | Reduce -10.8% | 43,468 | $119K |
| BlackRock Inc. | 0.00% | Reduce -2.3% | 30,440 | $83K |
| Tudor Investment Corporation | 0.00% | Reduce -0.1% | 29,466 | $81K |
| State Street Corp. | 0.00% | No change | 21,700 | $59K |
| Millennium Management | 0.00% | Add +9.1% | 20,106 | $55K |
| Chicago Partners Investment Group LLC | 0.00% | Reduce -0.5% | 12,104 | $45K |
| Renaissance Technologies | 0.00% | Add +0.1% | 10,617 | $29K |
| Osaic Holdings, Inc. | 0.00% | No change | 8,333 | $22K |
| UBS Group AG | 0.00% | New | 5,925 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +4.4% | 3,606 | $10K |
| Morgan Stanley | 0.00% | No change | 1,709 | $5K |
| Qube Research & Technologies Ltd | 0.00% | No change | 981 | $3K |
| Wells Fargo & Company | 0.00% | Add +4.2% | 50 | $137 |
| Royal Bank of Canada | 0.00% | Add +75.0% | 63 | $0 |
"% of holder's portfolio" is CLYM's weight in each manager's 13F, not the share of Climb Bio Inc. the manager owns.